Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$43.97 -0.63 (-1.41%)
At close: Sep 29, 2026 · 4:00 PM EDT

Supernus Pharmaceuticals (SUPN) Assets (2011 - 2026)

Updated

Supernus Pharmaceuticals (SUPN) posted Assets of $1.43 billion for Q2 2026, up 3.3% from $1.38 billion a year earlier but down 4.8% from the prior quarter.

Analysis

Supernus Pharmaceuticals (SUPN) Assets (2011 - 2026) Analysis & Trends

At the end of FY2025, Supernus Pharmaceuticals' Assets came in at $1.45 billion, up 6.2% from FY2024.

  • Annual Assets shows a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
  • In prior years, Supernus Pharmaceuticals' Assets was $1.37 billion in FY2024 (+7.1%), $1.28 billion in FY2023 (-25.0%), $1.7 billion in FY2022 (+0.8%) and $1.69 billion in FY2021 (+12.3%).
  • Quarterly Assets has run from a low of $1.28 billion in Q4 2023 to a high of $1.79 billion in Q1 2023 over five years.
  • On a year-over-year basis, Assets has increased in each of the last nine quarters, with growth averaging 5.8% over the last eight quarters.
  • The strongest year-over-year quarter for Assets in the past five years was Q4 2021, with growth of 12.3%; the weakest was Q1 2024, with a decline of 27.2%.
  • According to Business Quant data, Assets for the three prior quarters was $1.5 billion (Q1 2026), $1.45 billion (Q4 2025) and $1.42 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Supernus Pharmaceuticals 2.59 Bn 1.25 Bn 185.39 Mn 1.43 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.43 Bn
Mar 31, 2026 1.50 Bn
Dec 31, 2025 1.45 Bn
Sep 30, 2025 1.42 Bn
Jun 30, 2025 1.38 Bn
Mar 31, 2025 1.35 Bn
Dec 31, 2024 1.37 Bn
Sep 30, 2024 1.34 Bn
Jun 30, 2024 1.32 Bn
Mar 31, 2024 1.30 Bn
Dec 31, 2023 1.28 Bn
Sep 30, 2023 1.29 Bn
Jun 30, 2023 1.29 Bn
Mar 31, 2023 1.79 Bn
Dec 31, 2022 1.70 Bn
Sep 30, 2022 1.69 Bn
Jun 30, 2022 1.69 Bn
Mar 31, 2022 1.64 Bn
Dec 31, 2021 1.69 Bn
Sep 30, 2021 1.56 Bn
API Access

Supernus Pharmaceuticals Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=SUPN&period=max&api_key=YOUR_API_KEY